dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, January 25th--Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

Canadian resident pleads guilty in U.S. health care scam Sold device under false pretense of treating more than 200 diseases

FDA gives nod to MR-conditional labeling for Abbott ICD and CRT-D Labeling will reduce anxiety for patients who need scanning

Corindus and Mayo Clinic partner to study telestenting Can the CorPath GRX enable more patients to undergo PCI?

Alex Gorsky The American Heart Association names Johnson & Johnson Chairman & CEO as chairman of its CEO roundtable

Personalized medicine: The future of cardiology New technologies are improving cardiac care

Physicians halt life-threatening arrhythmias with stereotactic radiation First entirely noninvasive process proposed for treating ventricular tachycardia

Researchers develop new contrast agent for better MR detection of heart disease Reveals inflamed areas in resulting scans

Corindus announces first commercial installation of its CorPath GRX System outside U.S. Apex Heart Institute is the pioneer in India

Hitachi and Partners Connected Health assess readmission for heart failure with AI Assesses risk of readmission within the first 30 days following release

Researchers develop AI system to better detect risk of cancer in high-risk lesions Could reduce false positives and unnecessary surgeries

80 million Americans
now have access

Three health plans announce coverage for HeartFlow FFRct Analysis

by Lauren Dubinsky , Senior Reporter
Three health plans recently decided to provide coverage for the HeartFlow FFRct Analysis technology.

Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama provide health insurance for 44 million patients. After evaluating the technology’s technical performance, diagnostic accuracy, clinical utility and clinical benefits, they determined it’s medically necessary for members with stable chest pain after a coronary CT angiogram is performed.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



Coronary artery disease accounts for about one in every five deaths in developed countries, making it the most common cause of mortality in those regions, according to a study published in Mayo Clinic Proceedings. The HeartFlow Analysis evaluates the extent of CAD as well as the impact it has on blood flow to the heart.

Dr. John H. Stevens, president and CEO of HeartFlow, stated that an increasing number of national and regional commercial payors are providing coverage for the technology. That’s largely due to the evidence that it reduces the need for noninvasive and invasive tests and procedures, and lowers health care costs.

“With the growing number of health plans covering our technology, even more patients with suspected CAD will benefit by receiving a definitive personalized treatment plan based on the HeartFlow Analysis,” he said in a statement.

The other commercial payors include Aetna, which covers over 23 million lives, and additional Blue Cross Blue Shield companies that collectively have almost 5.5 million members. Nearly 80 million Americans now have access to HeartFlow Analysis.

The company that conducts health care technology evaluations for the Blue Cross Blue Shield Association is called Evidence Street. In June, it issued a review that determined HeartFlow Analysis provides a “meaningful improvement in net health outcome” in patients with stable chest pain.

The National Institute for Health and Care Excellence of the U.K.’s National Health Service, which covers 59 million lives, also issued guidance that recommended HeartFlow Analysis for determining the cause of stable chest pain.

The American College of Cardiology and the American Heart Association recently released Appropriate Use Criteria for patients with stable ischemic heart disease undergoing coronary revascularization. It included the use of HeartFlow Analysis for gauging the appropriateness of revascularization in many clinical scenarios.

In other news, Philips and HeartFlow Inc. announced a partnership on Monday to promote the combined use of HeartFlow Analysis and Philips’ advanced catheters. The companies have also entered a collaboration agreement to develop a cath lab X-ray image-derived fraction flow reserve or instant wave-free ratio solution.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED